Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Price, Quote, News and Overview

FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR

40.76  -0.13 (-0.32%)

FRE.DE Quote, Performance and Key Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (7/21/2025, 7:00:00 PM)

40.76

-0.13 (-0.32%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High44.4
52 Week Low30.36
Market Cap22.96B
Shares563.24M
Float411.39M
Yearly Dividend0
Dividend Yield2.42%
PE12.66
Fwd PE11
Earnings (Next)08-06 2025-08-06
IPO12-18 1986-12-18


FRE.DE short term performance overview.The bars show the price performance of FRE.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

FRE.DE long term performance overview.The bars show the price performance of FRE.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of FRE.DE is 40.76 EUR. In the past month the price decreased by -2.42%. In the past year, price increased by 27.93%.

FRESENIUS SE & CO KGAA / FRE Daily stock chart

FRE.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1CVS.MI CVS HEALTH CORP 11.79 69.19B
CVS.DE CVS HEALTH CORP 9.75 67.32B
FME.DE FRESENIUS MEDICAL CARE AG 13.92 26.54B
1FRE.MI FRESENIUS SE & CO KGAA 12.7 23.03B
V3V.DE FAMICORD AG 36.07 89.08M

About FRE.DE

Company Profile

FRE logo image Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.

Company Info

FRESENIUS SE & CO KGAA

Else-Kroener-Str. 1

BAD HOMBURG HESSEN DE

Employees: 177091

FRE Company Website

FRE Investor Relations

Phone: 4961726080

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the stock price of FRESENIUS SE & CO KGAA today?

The current stock price of FRE.DE is 40.76 EUR. The price decreased by -0.32% in the last trading session.


What is the ticker symbol for FRESENIUS SE & CO KGAA stock?

The exchange symbol of FRESENIUS SE & CO KGAA is FRE and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is FRE.DE stock listed?

FRE.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for FRESENIUS SE & CO KGAA stock?

23 analysts have analysed FRE.DE and the average price target is 49.47 EUR. This implies a price increase of 21.37% is expected in the next year compared to the current price of 40.76. Check the FRESENIUS SE & CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FRESENIUS SE & CO KGAA worth?

FRESENIUS SE & CO KGAA (FRE.DE) has a market capitalization of 22.96B EUR. This makes FRE.DE a Large Cap stock.


How many employees does FRESENIUS SE & CO KGAA have?

FRESENIUS SE & CO KGAA (FRE.DE) currently has 177091 employees.


What are the support and resistance levels for FRESENIUS SE & CO KGAA (FRE.DE) stock?

FRESENIUS SE & CO KGAA (FRE.DE) has a support level at 40.75 and a resistance level at 41.17. Check the full technical report for a detailed analysis of FRE.DE support and resistance levels.


Is FRESENIUS SE & CO KGAA (FRE.DE) expected to grow?

The Revenue of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 4.95% in the next year. Check the estimates tab for more information on the FRE.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FRESENIUS SE & CO KGAA (FRE.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FRESENIUS SE & CO KGAA (FRE.DE) stock pay dividends?

FRESENIUS SE & CO KGAA (FRE.DE) has a dividend yield of 2.42%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of FRE.DE dividend history, reliability and sustainability.


When does FRESENIUS SE & CO KGAA (FRE.DE) report earnings?

FRESENIUS SE & CO KGAA (FRE.DE) will report earnings on 2025-08-06.


What is the Price/Earnings (PE) ratio of FRESENIUS SE & CO KGAA (FRE.DE)?

The PE ratio for FRESENIUS SE & CO KGAA (FRE.DE) is 12.66. This is based on the reported non-GAAP earnings per share of 3.22 and the current share price of 40.76 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FRE.DE.


FRE.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to FRE.DE. When comparing the yearly performance of all stocks, FRE.DE is one of the better performing stocks in the market, outperforming 75.61% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FRE.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE. The financial health of FRE.DE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FRE.DE Financial Highlights

Over the last trailing twelve months FRE.DE reported a non-GAAP Earnings per Share(EPS) of 3.22. The EPS increased by 785.11% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.91%
ROA 0.98%
ROE 2.17%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%31.34%
Sales Q2Q%-0.93%
EPS 1Y (TTM)785.11%
Revenue 1Y (TTM)-20.12%

FRE.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to FRE.DE. The Buy consensus is the average rating of analysts ratings from 23 analysts.

For the next year, analysts expect an EPS growth of 10.09% and a revenue growth 4.95% for FRE.DE


Ownership
Inst Owners36.44%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts83.48
Price Target49.47 (21.37%)
EPS Next Y10.09%
Revenue Next Year4.95%